Patents by Inventor Andrew Lewis Theophilus

Andrew Lewis Theophilus has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline complexes of fluticasone-2-furoate
    Patent number: 7592329
    Abstract: There is provided a crystalline complex comprising a compound of formula (I) in which the crystal lattice is stabilized by the presence of a guest molecule, characterized in that the crystalline complex is of space group P212121 having unit cell dimensions of about 12.5±1.0 §, 15±1.0 §, and 16.2±1.0 § when determined at either 120K or 150K.
    Type: Grant
    Filed: February 4, 2003
    Date of Patent: September 22, 2009
    Assignee: Glaxo Group Limited
    Inventors: Keith Biggadike, Steven John Coote, Andrew Craig, David Malcolm Crowe, Victor Witold Jacewicz, Michael John Millan, Rosalyn Kay Nice, Brian Noga, John Frederick Seager, Andrew Lewis Theophilus
  • Novel process for preparing crystalline particles
    Publication number: 20040091407
    Abstract: The present invention relates to a novel process for preparing crystalline particles of a salt of a substance, particularly particles of therapeutically useful or carrier substances of a size suitable for inhalation therapy.
    Type: Application
    Filed: June 6, 2003
    Publication date: May 13, 2004
    Inventors: Robert William Lancaster, Hardev Singh, Andrew Lewis Theophilus
  • Novel process for preparing and harvesting crystalline particles
    Publication number: 20040045805
    Abstract: The present invention relates to a novel process for preparing and harvesting crystalline particles, particularly particles of therapeutically useful or carrier substances of a size suitable for inhalation therapy.
    Type: Application
    Filed: June 6, 2003
    Publication date: March 11, 2004
    Inventors: Robert William Lancaster, Hardev Singh, Andrew Lewis Theophilus